{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:13:39Z","timestamp":1790162019203,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-026-04358-w","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T09:35:13Z","timestamp":1777282513000},"page":"4714-4727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tozasertib\u2009+\u2009cisplatin inhibits proliferation, migration, and induces apoptosis in esophageal carcinoma cells"],"prefix":"10.1007","volume":"28","author":[{"given":"Chunqin","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lichun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5381-9383","authenticated-orcid":false,"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"issue":"7","key":"4358_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26071981","volume":"26","author":"NA Borah","year":"2021","unstructured":"Borah NA, Reddy MM. Aurora kinase B inhibition: a potential therapeutic strategy for cancer. Molecules. 2021;26(7):1981. https:\/\/doi.org\/10.3390\/molecules26071981.","journal-title":"Molecules"},{"issue":"3","key":"4358_CR2","first-page":"645","volume":"31","author":"CY Cheng","year":"2017","unstructured":"Cheng CY, Liu JC, Wang JJ, Li YH, Pan J, Zhang YR. Autophagy inhibition increased the anti-tumor effect of cisplatin on drug-resistant esophageal cancer cells. J Biol Regul Homeost Agents. 2017;31(3):645\u201352.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"3","key":"4358_CR3","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.19193\/0393-6384_2022_3_294","volume":"38","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Keita M, Si X. Analysis of endoscopic examination of esophageal diseases in Conakry, Guinea. Acta Med Mediterr. 2022;38(3):1919\u201322. https:\/\/doi.org\/10.19193\/0393-6384_2022_3_294.","journal-title":"Acta Med Mediterr"},{"issue":"1","key":"4358_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41416-023-02458-w","volume":"130","author":"HA Clements","year":"2024","unstructured":"Clements HA, Underwood TJ, Petty RD. Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma. Br J Cancer. 2024;130(1):9\u201318. https:\/\/doi.org\/10.1038\/s41416-023-02458-w.","journal-title":"Br J Cancer"},{"key":"4358_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh S. Cisplatin: the first metal-based anticancer drug. Bioorg Chem. 2019;88:102925. https:\/\/doi.org\/10.1016\/j.bioorg.2019.102925.","journal-title":"Bioorg Chem"},{"issue":"3","key":"4358_CR6","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.chembiol.2018.11.005","volume":"26","author":"SM Hanson","year":"2019","unstructured":"Hanson SM, Georghiou G, Thakur MK, Miller WT, Rest JS, Chodera JD, et al. What makes a kinase promiscuous for inhibitors? Cell Chem Biol. 2019;26(3):390-399.e5. https:\/\/doi.org\/10.1016\/j.chembiol.2018.11.005.","journal-title":"Cell Chem Biol"},{"key":"4358_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.856831","volume":"12","author":"C Huang","year":"2022","unstructured":"Huang C, Xu S, Luo Z, Li D, Wang R, Wang T. Epidemiological evidence between variants in matrix metalloproteinases-2, -7, and -9 and cancer risk. Front Oncol. 2022;12:856831. https:\/\/doi.org\/10.3389\/fonc.2022.856831.","journal-title":"Front Oncol"},{"issue":"2","key":"4358_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13020520","volume":"13","author":"J Ismail","year":"2025","unstructured":"Ismail J, Shebaby W, Azar Atallah S, Taleb RI, Kawrani S, Faour W, et al. Combination of Cannabidiol with Cisplatin or Paclitaxel analysis using the Chou-Talalay method and chemo-sensitization evaluation in Platinum-resistant ovarian cancer cells. Biomedicines. 2025;13(2):520. https:\/\/doi.org\/10.3390\/biomedicines13020520.","journal-title":"Biomedicines"},{"issue":"7","key":"4358_CR9","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1080\/13543776.2021.1890027","volume":"31","author":"XL Jing","year":"2021","unstructured":"Jing XL, Chen SW. Aurora kinase inhibitors: a patent review (2014-2020). Expert Opin Ther Pat. 2021;31(7):625\u201344. https:\/\/doi.org\/10.1080\/13543776.2021.1890027.","journal-title":"Expert Opin Ther Pat"},{"issue":"9","key":"4358_CR10","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/CAD.0000000000001089","volume":"32","author":"J Kou","year":"2021","unstructured":"Kou J, Wang X, Wei Y, Zhao R, Wang X, He J, et al. Aurora kinase inhibitor VX-680 enhances the sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy. Anticancer Drugs. 2021;32(9):969\u201377. https:\/\/doi.org\/10.1097\/CAD.0000000000001089.","journal-title":"Anticancer Drugs"},{"issue":"5","key":"4358_CR11","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog4905113","volume":"49","author":"A Lee","year":"2022","unstructured":"Lee A, Yoon J, Oh S, Lee J, Kim S, Hyun AK, et al. Neoadjuvant chemotherapy with quick cisplatin-VP 16 followed by robotic radical trachelectomy in FIGO 2018 stage 1B2 cervical cancer. Clin Exp Obstet Gynecol. 2022;49(5):113. https:\/\/doi.org\/10.31083\/j.ceog4905113.","journal-title":"Clin Exp Obstet Gynecol"},{"issue":"1","key":"4358_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1515\/iss-2023-0005","volume":"10","author":"F Malekzada","year":"2024","unstructured":"Malekzada F, Vladimiriov M, Leitz M, Michel J, Nimzewski F, Hoeppner J. Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy. Innov Surg Sci. 2024;10(1):3\u20139. https:\/\/doi.org\/10.1515\/iss-2023-0005.","journal-title":"Innov Surg Sci"},{"issue":"15","key":"4358_CR13","doi-asserted-by":"publisher","first-page":"10621","DOI":"10.1021\/acs.joc.1c01269","volume":"86","author":"L Marek","year":"2021","unstructured":"Marek L, V\u00e1\u0148a J, Svoboda J, Hanusek J. Synthesis of the kinase inhibitors nintedanib, hesperadin, and their analogues using the Eschenmoser coupling reaction. J Org Chem. 2021;86(15):10621\u20139. https:\/\/doi.org\/10.1021\/acs.joc.1c01269.","journal-title":"J Org Chem"},{"issue":"2","key":"4358_CR14","first-page":"455","volume":"59","author":"CS Melincovici","year":"2018","unstructured":"Melincovici CS, Bo\u015fca AB, \u015eu\u015fman S, M\u0103rginean M, Mihu C, Istrate M, et al. Vascular endothelial growth factor (VEGF) is a key factor in normal and pathological angiogenesis. Rom J Morphol Embryol. 2018;59(2):455\u201367.","journal-title":"Rom J Morphol Embryol"},{"key":"4358_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ab.2020.113608","volume":"593","author":"L Pillai-Kastoori","year":"2020","unstructured":"Pillai-Kastoori L, Schutz-Geschwender AR, Harford JA. A systematic approach to quantitative Western blot analysis. Anal Biochem. 2020;593:113608. https:\/\/doi.org\/10.1016\/j.ab.2020.113608.","journal-title":"Anal Biochem"},{"issue":"9","key":"4358_CR16","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1038\/s41591-024-03064-w","volume":"30","author":"J Qin","year":"2024","unstructured":"Qin J, Xue L, Hao A, Guo X, Jiang T, Ni Y, et al. Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO\/NCCES01 trial. Nat Med. 2024;30(9):2549\u201357. https:\/\/doi.org\/10.1038\/s41591-024-03064-w.","journal-title":"Nat Med"},{"issue":"2","key":"4358_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/14728222.2022.2036718","volume":"26","author":"JE Rogers","year":"2022","unstructured":"Rogers JE, Sewastjanow-Silva M, Waters RE, Ajani JA. Esophageal cancer: emerging therapeutics. Expert Opin Ther Targets. 2022;26(2):107\u201317. https:\/\/doi.org\/10.1080\/14728222.2022.2036718.","journal-title":"Expert Opin Ther Targets"},{"issue":"4","key":"4358_CR18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.clgc.2021.01.006","volume":"19","author":"E Rossini","year":"2021","unstructured":"Rossini E, Bosatta V, Abate A, Fragni M, Salvi V, Basnet RM, et al. Cisplatin cytotoxicity in human testicular germ cell tumor cell lines is enhanced by the CDK4\/6 inhibitor palbociclib. Clin Genitourin Cancer. 2021;19(4):316\u201324. https:\/\/doi.org\/10.1016\/j.clgc.2021.01.006.","journal-title":"Clin Genitourin Cancer"},{"issue":"5","key":"4358_CR19","first-page":"536","volume":"66","author":"M Roupr\u00eat","year":"2013","unstructured":"Roupr\u00eat M. How could molecular biology modify the management of upper urinary tract tumours? Arch Esp Urol. 2013;66(5):536\u201342.","journal-title":"Arch Esp Urol"},{"issue":"11","key":"4358_CR20","doi-asserted-by":"publisher","first-page":"5655","DOI":"10.21873\/anticanres.16074","volume":"42","author":"H Sato","year":"2022","unstructured":"Sato H, Nishikawa K, Hamakawa T, Kusunoki C, Miyake M, Miyamoto A, et al. Evaluating neoadjuvant chemotherapy for lower esophageal squamous cell carcinoma by measuring esophageal wall thickness. Anticancer Res. 2022;42(11):5655\u201362. https:\/\/doi.org\/10.21873\/anticanres.16074.","journal-title":"Anticancer Res"},{"issue":"1","key":"4358_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41591-018-0264-7","volume":"25","author":"KN Shah","year":"2019","unstructured":"Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, et al. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med. 2019;25(1):111\u20138. https:\/\/doi.org\/10.1038\/s41591-018-0264-7.","journal-title":"Nat Med"},{"issue":"1","key":"4358_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1021\/acsmedchemlett.2c00446","volume":"14","author":"C Wang","year":"2022","unstructured":"Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, et al. Discovery of coumarin-based MEK1\/2 PROTAC effective in human cancer cells. ACS Med Chem Lett. 2022;14(1):92\u2013102. https:\/\/doi.org\/10.1021\/acsmedchemlett.2c00446.","journal-title":"ACS Med Chem Lett"},{"issue":"3","key":"4358_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031868","volume":"23","author":"D Winardi","year":"2022","unstructured":"Winardi D, Chu PY, Chen GY, Wang K, Hsu WY, Hsieh CL, et al. Novel aurora A kinase inhibitor fangchinoline enhances cisplatin-DNA adducts and cisplatin therapeutic efficacy in OVCAR-3 ovarian cancer cells-derived xenograft model. Int J Mol Sci. 2022;23(3):1868. https:\/\/doi.org\/10.3390\/ijms23031868.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4358_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12531-z","volume":"24","author":"M Zhang","year":"2024","unstructured":"Zhang M, Li Z, Yin Y. Association of effective dose to immune cells and vertebral marrow dose with hematologic toxicity during neoadjuvant chemoradiotherapy in esophageal squamous cell carcinoma. BMC Cancer. 2024;24(1):779. https:\/\/doi.org\/10.1186\/s12885-024-12531-z.","journal-title":"BMC Cancer"},{"key":"4358_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cellsig.2018.12.007","volume":"55","author":"Y Zhao","year":"2019","unstructured":"Zhao Y, Xia Q, Liu Y, Bai W, Yao Y, Ding J, et al. TCF7L2 and EGR1 synergistically activate transcription of LCN2 via an ERK1\/2-dependent pathway in esophageal squamous cell carcinoma cells. Cell Signal. 2019;55:8\u201316. https:\/\/doi.org\/10.1016\/j.cellsig.2018.12.007.","journal-title":"Cell Signal"},{"key":"4358_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1565638","volume":"15","author":"J Zhu","year":"2025","unstructured":"Zhu J, Zheng Z, Yin Z, Ding L, Li C, Wang X, et al. MiR-146b overexpression promotes bladder cancer cell growth via the SMAD4\/C-MYC\/Cyclin D1 axis. Front Oncol. 2025;15:1565638. https:\/\/doi.org\/10.3389\/fonc.2025.1565638.","journal-title":"Front Oncol"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04358-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-026-04358-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-026-04358-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T10:41:35Z","timestamp":1790160095000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-026-04358-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":26,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["4358"],"URL":"https:\/\/doi.org\/10.1007\/s12094-026-04358-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethical approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}